The advances taking place on
tissues today are jaw dropping. We are
approaching the capability to trade out failed parts of the body as a matter of
routine surgery. They will be replaced
with new components reconstructed using ones own cells.
I recently saw the demonstration
of a swine kidney on NOVA been cleansed of all swine cells that could then be
used to house human cells and be then transplanted into a human in need. They have already achieved something like all
this with the heart. They got the result
beating! Importantly, the time from recognizing
possibility to demonstration was quick.
This should have had an unending series of glitches. This means that perfecting all this is going
to be rapid and decades have already become years and probably we are actually
dealing in months.
What is have actually seen this
past couple of years tells me that the available tool kit is already sufficient
to systematically restore the majority of the human body. It will soon be into the tweaking stage.
This item tells us that a
remaining road block is on the way to been removed. We have now successfully grown blood cells.
blood vessels for lab-grown tissues
Rice, BCM discovery addresses key roadblock to growing replacement tissues, organs
Researchers from Rice University and Baylor College
of Medicine (BCM) have broken one of the major roadblocks on the path to
growing transplantable tissue in the lab: They've found a way to grow the blood
vessels and capillaries needed to keep tissues alive.
The new research is available online and due to appear in the January
issue of the journal Acta Biomaterialia.
"The inability to grow blood-vessel networks -- or vasculature --
in lab-grown tissues is the leading problem in regenerative medicine
today," said lead co-author Jennifer West, department chair and the Isabel
C. Cameron Professor of Bioengineering at Rice. "If you don't have blood
supply, you cannot make a tissue structure that is thicker than a couple hundred
microns."
As its base material, a team of researchers led by West and BCM
molecular physiologist Mary Dickinson chose polyethylene glycol (PEG), a
nontoxic plastic that's widely used in medical devices and food. Building on 10
years of research in West's lab, the scientists modified the PEG to mimic the
body's extracellular matrix -- the network of proteins and polysaccharides that
make up a substantial portion of most tissues.
West, Dickinson, Rice graduate student Jennifer Saik, Rice
undergraduate Emily Watkins and Rice-BCM graduate student Daniel Gould combined
the modified PEG with two kinds of cells -- both of which are needed for
blood-vessel formation. Using light that locks the PEG polymer strands into a
solid gel, they created soft hydrogels that contained living cells and growth
factors. After that, they filmed the hydrogels for 72 hours. By tagging each
type of cell with a different colored fluorescent marker, the team was able to
watch as the cells gradually formed capillaries throughout the soft, plastic
gel.
To test these new vascular networks, the team implanted the hydrogels
into the corneas of mice, where no natural vasculature exists. After injecting
a dye into the mice's bloodstream, the researchers confirmed normal blood flow
in the newly grown capillaries.
Another key advance, published by West and graduate student Joseph
Hoffmann in November, involved the creation of a new technique called
"two-photon lithography," an ultrasensitive way of using light to
create intricate three-dimensional patterns within the soft PEG hydrogels. West
said the patterning technique allows the engineers to exert a fine level of
control over where cells move and grow. In follow-up experiments, also in
collaboration with the Dickinson
lab at BCM, West and her team plan to use the technique to grow blood vessels
in predetermined patterns.
The research was supported by the National Science Foundation and the
National Institutes of Health. West's work was conducted in her lab at Rice's
BioScience Research Collaborative (BRC). The BRC is an innovative space where
scientists and educators from Rice University and other Texas Medical
Center institutions work
together to perform leading research that benefits human medicine and health.
I wonder how the capacity to grow human blood cells will affect non-profits that have blood drives. It would seem to be pointless to deal with the testing and limitations on frequency of blood donation should blood-growers be available. Maybe hospitals could have their own equipment to constantly grow blood for surgery; blood-on-demand may become feasible.
ReplyDelete